A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 233,833 shares of FOLD stock, worth $2.26 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
233,833
Previous 235,582 0.74%
Holding current value
$2.26 Million
Previous $2.34 Million 6.89%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$9.55 - $12.09 $16,702 - $21,145
-1,749 Reduced 0.74%
233,833 $2.5 Million
Q2 2024

Aug 14, 2024

BUY
$9.04 - $11.75 $2.13 Million - $2.77 Million
235,582 New
235,582 $2.34 Million

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.71B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.